Tips for managing Sleep Problems (Insomnia) in the Cancer Patient
Carolyn Vachani, MSN, RN, AOCN
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: February 14, 2013
What is Insomnia?
Insomnia, or trouble sleeping, is a common problem for patients with cancer. It can present as difficulty falling asleep, multiple awakenings during the night or early morning with the inability to get back to sleep. Insomnia can lead to fatigue, memory and concentration problems, mood disturbances and psychiatric disorders.
What are the causes of insomnia?
Risk factors include: personal or family history of insomnia, depression, anxiety disorder, advanced age, and female gender.
Causes can include: medications, recent or prolonged hospitalization, chemo, radiation, or hormonal therapy, pain, hot flashes, nausea and vomiting.
Easily modifiable causes include: irregular sleep schedule, excessive amount of time spent in bed, napping, engaging in sleep-interfering activities in bed (TV watching or reading), and unrealistic sleep expectations.
How should insomnia be treated?
Treat the underlying cause of the insomnia, including pain, nausea, depression and hot flashes.
A combination of prescription medication and psychological therapy may be beneficial for short-term relief.
Hypnotic medications are most commonly used, but they can result in residual next-day effects, risk of dependence, and rebound insomnia when stopped.
These medications should not be taken for more than 2-4 weeks and do not mix with other sedating agents or alcohol.
Over-the-counter "sleep aids" should be used with caution.
Many of these agents contain antihistamines, which can cause sleepiness, but may be less effective than prescription medications and may have additional side effects.
Over-the-counter herbal products such as, melatonin, kava-kava and valerian should be used with caution.
May 25, 2010 - In cancer survivors who report sleeping problems after completing adjuvant therapy, a yoga program may lead to better sleep, less fatigue and an improved quality of life, according to a study released May 20 in advance of the American Society of Clinical Oncology's 46th Annual Meeting, to be held June 4-8 in Chicago.